Michael Jarsch

Person

Bad Heilbrunn, DE

People

Patents Grantslast 30 patents

Information Patent Grant
Antibodies against human EPO receptor
- Patent number 9,221,909
- Issue date Dec 29, 2015
- HOFFMANN-LA ROCHE INC.
- Michael Jarsch
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-human EPO receptor antibodies and methods of use
- Patent number 9,187,563
- Issue date Nov 17, 2015
- HOFFMANN-LA ROCHE INC.
- Michael Jarsch
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Method for detecting erythropoietin (EPO) receptor using anti-human...
- Patent number 8,623,666
- Issue date Jan 7, 2014
- Hoffmann-La Roche Inc.
- Michael Jarsch
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Cholesterol oxidase from Brevibacterium sterolicum
- Patent number 5,916,759
- Issue date Jun 29, 1999
- Boehringer Mannheim GmbH
- Michael Jarsch
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Recombinant DNA and expression vector for the repressible and induc...
- Patent number 5,830,720
- Issue date Nov 3, 1998
- Boehringer Mannheim GmbH
- August Bock
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Process for the production and renaturation of recombinant, biologi...
- Patent number 5,434,067
- Issue date Jul 18, 1995
- Boehringer Mannheim GmbH
- Uwe Michaelis
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Cloning and overexpression of glucose-6-phosphate dehydrogenase fro...
- Patent number 5,308,770
- Issue date May 3, 1994
- Boehringer Mannheim GmbH
- Michael Jarsch
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Cloning and overexpression of glucose-6-phosphate dehydrogenase fro...
- Patent number 5,229,286
- Issue date Jul 20, 1993
- Boehringer Mannheim GmbH
- Michael Jarsch
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Type II restriction endonuclease Ssp4800I
- Patent number 5,183,747
- Issue date Feb 2, 1993
- Boehringer Mannheim GmbH
- Klaus Kaluza
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Type II restriction endonuclease SwaI
- Patent number 5,158,878
- Issue date Oct 27, 1992
- Boehringer Mannheim GmbH
- Barbara Prinz
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Type II restriction endonuclease MamI
- Patent number 5,153,122
- Issue date Oct 6, 1992
- Boehringer Mannheim GmbH
- Klaus Kaluza
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Type II restriction endonucleae MCRI
- Patent number 5,134,068
- Issue date Jul 28, 1992
- Boehringer Mannheim GmbH
- Klaus Kaluza
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Type II restriction endonuclease RleAI
- Patent number 5,134,067
- Issue date Jul 28, 1992
- Boehringer Mannheim GmbH
- Klaus Kaluza
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Type II restriction endonuclease SgrAI
- Patent number 5,134,069
- Issue date Jul 28, 1992
- Boehringer Mannheim GmbH
- Klaus Kaluza
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Class II restriction endonuclease KspI and a process for obtaining it
- Patent number 4,975,376
- Issue date Dec 4, 1990
- Boehringer Mannheim GmbH
- Bryan J. Bolton
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Class II restriction endonuclease Ksp632I, a process for obtaining...
- Patent number 4,970,149
- Issue date Nov 13, 1990
- Boehringer Mannheim GmbH
- Bryan J. Bolton
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Patents Applicationslast 30 patents

Information Patent Application
Methods For The Prediction Of A Personalized ESA-Dose In The Treatm...
- Publication number 20170128532
- Publication date May 11, 2017
- HOFFMANN-LA ROCHE, INC.
- Augustin Rodriguez
- G01 - MEASURING TESTING
Information Patent Application
ANTI-HUMAN EPO RECEPTOR ANTIBODIES AND METHODS OF USE
- Publication number 20140193418
- Publication date Jul 10, 2014
- Hoffmann-La Roche Inc.
- Michael Jarsch
- G01 - MEASURING TESTING
Information Patent Application
ANTI-HUMAN EPO RECEPTOR ANTIBODIES AND METHODS OF USE
- Publication number 20120321633
- Publication date Dec 20, 2012
- Hoffmann-La Roche Inc.
- Michael Jarsch
- G01 - MEASURING TESTING
Information Patent Application
ANTIBODIES AGAINST HUMAN EPO RECEPTOR
- Publication number 20120122120
- Publication date May 17, 2012
- Hoffmann-La Roche Inc.
- Michael Jarsch
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODIES AGAINST HUMAN EPO RECEPTOR
- Publication number 20110165592
- Publication date Jul 7, 2011
- HOFFMAN-LA ROCHE INC.
- Michael Jarsch
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODIES AGAINST HUMAN EPO RECEPTOR
- Publication number 20110143372
- Publication date Jun 16, 2011
- Hoffman-La Roche, Inc.
- Michael Jarsch
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Treatment of neurodegenerative disorders
- Publication number 20100267632
- Publication date Oct 21, 2010
- Anton Haselbeck
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Treatment of neurodegenerative disorders
- Publication number 20070072795
- Publication date Mar 29, 2007
- Anton Haselbeck
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Michael Jarsch

Person

Patents Grantslast 30 patents

Antibodies against human EPO receptor

Anti-human EPO receptor antibodies and methods of use

Method for detecting erythropoietin (EPO) receptor using anti-human...

Cholesterol oxidase from Brevibacterium sterolicum

Recombinant DNA and expression vector for the repressible and induc...

Process for the production and renaturation of recombinant, biologi...

Cloning and overexpression of glucose-6-phosphate dehydrogenase fro...

Cloning and overexpression of glucose-6-phosphate dehydrogenase fro...

Type II restriction endonuclease Ssp4800I

Type II restriction endonuclease SwaI

Type II restriction endonuclease MamI

Type II restriction endonucleae MCRI

Type II restriction endonuclease RleAI

Type II restriction endonuclease SgrAI

Class II restriction endonuclease KspI and a process for obtaining it

Class II restriction endonuclease Ksp632I, a process for obtaining...

Patents Applicationslast 30 patents

Methods For The Prediction Of A Personalized ESA-Dose In The Treatm...

ANTI-HUMAN EPO RECEPTOR ANTIBODIES AND METHODS OF USE

ANTI-HUMAN EPO RECEPTOR ANTIBODIES AND METHODS OF USE

ANTIBODIES AGAINST HUMAN EPO RECEPTOR

ANTIBODIES AGAINST HUMAN EPO RECEPTOR

ANTIBODIES AGAINST HUMAN EPO RECEPTOR

Treatment of neurodegenerative disorders

Treatment of neurodegenerative disorders